InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: tcm55 post# 14605

Friday, 05/28/2021 1:01:56 AM

Friday, May 28, 2021 1:01:56 AM

Post# of 16706
DMT is not a second path. It's a new path in the pipeline that deviates from the "Repurposed Drugs Strategy". AP is no longer a Ph2 entry level company. Time and money is now being spent on a Phase 1 drug that has zero regulatory approval in North America. It remains a Schedule 1 drug just like Cannabis and Cocaine. How many years have they talked about legalizing pot in all of the USA? It remains a mountain to climb whether it's dems or repubs in charge. So too will DMT and all the other psychedelics out there. The one shot at success might come in the form of a potential psychedelic partnership deal as I've previously mentioned here. A mass influx of cash is common shareholders best shot at making any good of a new path that Doc Williams is credited for brainstorming how to get AP into the psychedelic game. I won't be around to see DMT through to a conclusion. Lord willing someone comes to the rescue and buys out the company for a decent price. Meanwhile, you claim to know stuff but miss a lot of the important parts that are known facts. As always, have at it. I'll be here speaking truth to power as always.

M$

M$ Ball Marker :-D

1907 Proof Saint-Gaudens Gold Double Eagle
Ultra High Relief Lettered Edge
Value: $2,990,000